Improving access to clinical trials in underserved states
Official title: The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and Workforce Development
Funded at West Virginia University · NIH-11141437 · Data updated 2026-11-12
This study is working to make more clinical trials available in certain areas by helping local hospitals and research centers connect better with those offering trials, so that patients can have more chances to participate in important studies that could benefit their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | West Virginia University NIH-funded |
| Lab location | 1 site (Morgantown, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $838,718 |
| NIH project number | 3U24GM150446-02S2 |
| Project ID | NIH-11141437 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are patients residing in IDeA states who are interested in participating in clinical trials for various health conditions.
✕Less likely to help
Patients living outside of IDeA states or those who are not interested in participating in clinical trials may not benefit from this research.
What this research studies
This research aims to enhance the availability of clinical trials in Institutional Development Award (IDeA) states by improving communication between local institutions and clinical trial sponsors. It focuses on establishing a resource center that will facilitate better marketing of trial opportunities and develop a workforce of trained clinical research coordinators. By addressing the barriers to participation, such as contract negotiation and IRB approval times, the project seeks to increase the number of clinical trials conducted in these regions, ultimately benefiting patients who may not have access to such opportunities.
Why it matters
Potential benefit: If successful, this research could significantly increase patient access to clinical trials, leading to more treatment options and improved health outcomes.
How similar studies have gone: Similar initiatives have shown promise in increasing clinical trial participation in underserved areas, indicating that this approach could be effective.
Where this research is happening
-
West Virginia University
Morgantown, United States Active
Researchers
- Principal investigator: Hodder, Sally Lynn — West Virginia University
- Study coordinator: Hodder, Sally Lynn
Related research
Other NIH-funded projects on the same topics.
-
West Virginia Rural Roots to Research: bringing clinical trials to Appalachian communities
A wide-network program in rural West Virginia is building patient-friendly clinical trials so people in Appalachia have better access to new cancer treatments and care.
-
CD38-Driven Changes in Brain Tumor Metabolism and Immunity in Glioblastoma
A patient-facing look at how scientists plan to study how glioblastoma grows by changing its metabolism and dampening the immune response, with potential targets to help treatment in the future.
-
Combinatorial targeting for high-risk B-cell ALL treatment
A research effort at West Virginia University is exploring a combination therapy for adult B-cell acute lymphoblastic leukemia using targeted gene silencing and a small-molecule compound to improve treatment in patients.
-
New mRNA vaccines and antibody therapies to prevent and treat pertussis
A program to create and test new mRNA vaccines and antibody therapies to stop whooping cough from spreading and causing illness in people of all ages.
-
Targeting teens’ social media use and real-time chats to improve well-being
A teen-focused program tests whether reducing social media, boosting real-time conversations, or journaling can improve well-being in 10th graders.
-
Molecular Regulators of Cone Opsin Trafficking
A study to understand how light-sensitive cone proteins are moved to the part of the eye that detects light, with the goal of helping people with certain inherited eye diseases.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.